Overview & Summary
A single-page pulse of Zyax Chem's financial position — payables, receivables, inventory health, sales performance and cash, as of 29 Aug 2026.
Sales run-rate vs monthly target
₹ lakh, Apr – Aug FY26Working capital position
Payables vs receivablesInventory ageing exposure
₹, by expiry bucketSales mix by category
Apr – Aug actual billingKey observations for the board
Auto-derived from source dataAccounts Payable
Sundry creditors closing balance as on 29 Aug 2026, grouped by expense and purchase ledgers.
Payables by ledger group
Expenses vs Purchase, ₹Top 10 creditors
By outstanding valueInsights & observations
Debit vs credit by group
₹Creditor ledger
| Party | Ledger Group | Debit (₹) | Credit (₹) | Net Payable (₹) |
|---|
Accounts Receivable
Sundry debtors closing balance, 1 Apr 2025 – 29 Aug 2026, grouped by business division.
Receivables by division
Net outstanding, ₹Debit vs credit balances
By divisionTop outstanding accounts
| Name | Division | Debit (₹) | Credit (₹) | Net (₹) |
|---|
Insights & observations
Inventory
Consolidated stock across Fort office and Mahul plant, valued at cost, with expiry-based ageing. Report date 19 Aug 2026.
Ageing profile
Value by expiry bucket, ₹Value by brand / category
Fort + Mahul combinedHighest-value expired stock
Top lines by ₹ value| Product | Brand | Location | Qty | Value (₹) | Expiry |
|---|
Observations
Sales MIS
Monthly billing achievement across six category groups, April – August 2026 (billed & booked so far this month for August).
Monthly billing trend
Actual vs target, ₹ lakhCategory share of total billing
Apr – Aug cumulativeSPOC leaderboard
Total billing owned, Apr – AugInsights & observations
Profit & Loss
Monthly income statement, April – August FY26.
Revenue, gross profit & EBITDA
₹ lakhMargin trend
% of revenueOpex breakdown
Selected month, % of opexMonthly statement
| Line item |
|---|
Cashflow
Monthly cash movement, April – August FY26.
Cash balance trend
₹ lakh, opening → closingCashflow by activity
Operating / investing / financingMonthly cashflow statement
| Line item |
|---|
Annual Operating Plan — FY26-27
Net Sales target of ₹9.0 Cr with ₹1.0 Cr Net Profit (11.1% margin), phased across the year with category-wise allocation.